AORT vs SIBN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

AORT

66.2
AI Score
VS
AORT Wins

SIBN

59.7
AI Score

Investment Advisor Scores

AORT

Oct 01, 2026
66score
Recommendation
HOLD

SIBN

Oct 01, 2026
60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AORT SIBN Winner
Forward P/E 35.3357 0 Tie
PEG Ratio 181.5 0 Tie
Revenue Growth 11.3% 15.2% SIBN
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 66.2/100 59.7/100 AORT
Profit Margin -0.7% -6.9% AORT
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

AORT 1M: -18.5% · 3M: -7.9% SIBN 1M: -2.1% · 3M: +8.2%

Current Technical Phase

AORT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.1 · Price: $22.08

SIBN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $18.52

Fundamentals Snapshot

Metric AORT SIBN
Market Cap — —
Forward P/E 29.3 -55.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% -0.1%
EPS -0.06 -0.33
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AORT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.